Navigation Links
Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) congratulates Mario R. Capecchi today for the richly deserved honor of the 2007 Nobel Prize in Physiology or Medicine. Capecchi, who sits on FBR's Board of Governors, is currently a Distinguished Professor and Co-Chair of the Human Genetics Department at the University of Utah, School of Medicine.

"Groundbreaking research such as Dr. Capecchi's has enabled the study of diseases in a way never before thought possible," said FBR President Frankie L. Trull. "This further demonstrates the incredible power and promise of the humane use of animal models in medical research."

The Nobel Foundation recognized Capecchi and two other researchers for the discovery of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." Their studies resulted in genetically altered mouse models, innovating the way researchers work to combat such diseases as cancer, diabetes and Alzheimer's.

Capecchi's Nobel Prize-winning work involved gene targeting in mouse embryonic stem cells, allowing scientists to study the pathology of disease in a living system whose genes have been either inactivated or modified. Scientists can now target specific disease-causing genes in an effort to discover new cures or treatments that afflict both humans and animals.

Upon joining FBR's Board of Governors, Capecchi said, "I am a very strong advocate for the respect and support of animal research. My scientific life has been devoted to the use of mouse models for the understanding of the development of therapies of human disease as well as for the pathologies."

FBR's Board of Governors now includes ten Nobel Laureates. Capecchi is a recipient of numerous other awards, including the Albert Lasker Award in 2001.

FBR is the nation's foremost organization devoted to promoting public understanding, respect, and support for the humane and responsible use of animals in medical and scientific research. For more information on FBR, please visit its Web site at http://www.fbresearch.org.


'/>"/>
SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
5. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
6. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
7. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
10. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):